Sedana Medical AB (publ)
STO:SEDANA
Sedana Medical AB (publ)
Net Income (Common)
Sedana Medical AB (publ)
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Net Income (Common)
-kr10.7m
|
CAGR 3-Years
43%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Net Income (Common)
kr1.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Net Income (Common)
kr131.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Net Income (Common)
kr140.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
16%
|
|
|
Getinge AB
STO:GETI B
|
Net Income (Common)
kr1.6B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Net Income (Common)
kr498m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Sedana Medical AB (publ)
Glance View
Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
See Also
What is Sedana Medical AB (publ)'s Net Income (Common)?
Net Income (Common)
-10.7m
SEK
Based on the financial report for Dec 31, 2024, Sedana Medical AB (publ)'s Net Income (Common) amounts to -10.7m SEK.
What is Sedana Medical AB (publ)'s Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
8%
Over the last year, the Net Income (Common) growth was 82%. The average annual Net Income (Common) growth rates for Sedana Medical AB (publ) have been 43% over the past three years , 8% over the past five years .
You don't have any saved screeners yet